Differences in outcome for consecutive patients with diffuse large B-cell lymphoma before and after the advent of rituximab: a single-center experience

Author： Okamoto Akinao   Yanada Masamitsu   Inaguma Yoko   Tokuda Masutaka   Morishima Satoko   Kanie Tadaharu   Yamamoto Yukiya   Tsuzuki Motohiro   Akatsuka Yoshiki   Mizuta Shuichi   Okamoto Masataka   Emi Nobuhiko  

Publisher： Maney Publishing

ISSN： 1024-5332

Source： Hematology, Vol.18, Iss.2, 2013-03, pp. : 74-80

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rituximab in the treatment of diffuse large B-cell lymphoma primary of the lung

By Aviles Agustin   Nambo Maria J.   Huerta-Guzman Judith   Silva Luis   Neri Natividad  

Hematology, Vol. 18, Iss. 2, 2013-03 ,pp. : 81-84

Maney Publishing

Access to resources Recommend Favorite

Secondary central nervous system involvement in 599 patients with diffuse large B-cell lymphoma: are there any changes in the rituximab era?

By Deng Lijuan   Song Yuqin   Zhu Jun   Zheng Wen   Wang Xiaopei   Xie Yan   Lin Ningjing   Tu Meifeng   Ping Lingyan   Ying Zhitao   Liu Weiping   Zhang Chen  

International Journal of Hematology, Vol. 98, Iss. 6, 2013-12 ,pp. : 664-671

Springer Publishing Company

Access to resources Recommend Favorite

Importance of maintaining the relative dose intensity of CHOP-like regimens combined with rituximab in patients with diffuse large B-cell lymphoma

By Hirakawa Tsuneaki   Yamaguchi Hiroki   Yokose Norio   Gomi Seiji   Inokuchi Koiti   Dan Kazuo  

Annals of Hematology, Vol. 89, Iss. 9, 2010-09 ,pp. : 897-904

Springer Publishing Company

Access to resources Recommend Favorite

Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Chinese patients

By Li J.   Wang L.   Shen Y.   Xia Z.   Chen Y.   Chen Q.   Chen Y.   Zeng X.   You J.   Qian Y.   Shen Z.  

Annals of Hematology, Vol. 86, Iss. 9, 2007-09 ,pp. : 639-645

Springer Publishing Company

Access to resources Recommend Favorite

Gemcitabine, cisplatin and methylprednisolone (GEM-P) with or without Rituximab in relapsed and refractory patients with diffuse large B cell lymphoma (DLBCL)

By Sirohi Bhawna   Cunningham David   Norman Andy   Last Kim   Chau Ian   Horwich Alan   Oates Jacqui   Chong Geoffrey   Wotherspoon Andrew  

Hematology, Vol. 12, Iss. 2, 2007-04 ,pp. : 149-153

Maney Publishing

Access to resources Recommend Favorite